Connection

Yuko Palesch to Clinical Trials as Topic

Back to Details
This is a "connection" page, showing publications Yuko Palesch has written about Clinical Trials as Topic.
Yuko Palesch
Connection Strength
1.781
Clinical Trials as Topic
  1. Continuous covariate imbalance and conditional power for clinical trial interim analyses. Contemp Clin Trials. 2014 May; 38(1):9-18.
    View in: PubMed
    Score: 0.332
  2. Covariate imbalance and adjustment for logistic regression analysis of clinical trial data. J Biopharm Stat. 2013; 23(6):1383-402.
    View in: PubMed
    Score: 0.306
  3. Design and analysis plans. Front Neurol Neurosci. 2009; 25:76-77.
    View in: PubMed
    Score: 0.235
  4. Applying a phase II futility study design to therapeutic stroke trials. Stroke. 2005 Nov; 36(11):2410-4.
    View in: PubMed
    Score: 0.185
  5. Power of logrank test and Cox regression model in clinical trials with heterogeneous samples. Stat Med. 1997 Mar 15; 16(5):583-97.
    View in: PubMed
    Score: 0.102
  6. Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet. Stroke. 2017 03; 48(3):813-819.
    View in: PubMed
    Score: 0.102
  7. Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data. Stroke. 2016 12; 47(12):2931-2937.
    View in: PubMed
    Score: 0.100
  8. Regression analysis of ordinal stroke clinical trial outcomes: an application to the NINDS t-PA trial. Int J Stroke. 2014 Feb; 9(2):226-31.
    View in: PubMed
    Score: 0.079
  9. Clinical trial design in the neurocritical care unit. Neurocrit Care. 2012 Feb; 16(1):6-19.
    View in: PubMed
    Score: 0.072
  10. Using global statistical tests in long-term Parkinson's disease clinical trials. Mov Disord. 2009 Sep 15; 24(12):1732-9.
    View in: PubMed
    Score: 0.061
  11. The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials. J Subst Abuse Treat. 2009 Jul; 37(1):54-63.
    View in: PubMed
    Score: 0.057
  12. Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials. Clin Trials. 2005; 2(6):509-18.
    View in: PubMed
    Score: 0.044
  13. Blood Pressure-Attained Analysis of ATACH 2 Trial. Stroke. 2018 06; 49(6):1412-1418.
    View in: PubMed
    Score: 0.028
  14. Multi-modality neuro-monitoring: conventional clinical trial design. Neurocrit Care. 2015 Jun; 22(3):369-77.
    View in: PubMed
    Score: 0.023
  15. Lessons from adult stroke trials. Pediatr Neurol. 2006 Jun; 34(6):446-9.
    View in: PubMed
    Score: 0.012
  16. Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology. 2006 Mar 14; 66(5):628-33.
    View in: PubMed
    Score: 0.012
  17. A responsive outcome for Parkinson's disease neuroprotection futility studies. Ann Neurol. 2005 Feb; 57(2):197-203.
    View in: PubMed
    Score: 0.011
  18. The role of radiotracer imaging in Parkinson disease. Neurology. 2005 Jan 25; 64(2):208-15.
    View in: PubMed
    Score: 0.011
  19. Analysis of clustered matched-pair data. Stat Med. 2003 Aug 15; 22(15):2417-28.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.